Trials / Completed
CompletedNCT01117792
Subcutaneous Implantable Defibrillator (S-ICD) System - CE Clinical Investigation
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 55 (actual)
- Sponsor
- Boston Scientific Corporation · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective is to evaluate the S-ICD system's ability to identify and terminate induced ventricular fibrillation in patients during the implant procedure. The safety and performance of the S-ICD system will also be assessed throughout the patient follow-up period.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | subcutaneous implantable defibrillator (S-ICD) system | implantable defibrillator system |
Timeline
- Start date
- 2008-12-01
- Primary completion
- 2009-03-01
- Completion
- 2009-08-01
- First posted
- 2010-05-05
- Last updated
- 2021-07-02
- Results posted
- 2021-07-02
Locations
8 sites across 4 countries: Italy, Netherlands, New Zealand, United Kingdom
Source: ClinicalTrials.gov record NCT01117792. Inclusion in this directory is not an endorsement.